Geoff Mackay's most recent trade in Tectonic Therapeutic Inc. was a trade of 300,667 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 8, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 300,667 | 300,667 | - | - | Restricted Stock Unit | |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2022 | 245,123 | 142,013 (0%) | 0% | 0 | Common Stock | |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2022 | 245,123 | 445,123 (1%) | 0% | 0 | Common Stock | |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2022 | 45,999 | 0 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.91 per share. | 28 Dec 2022 | 45,999 | 188,012 (0%) | 0% | 0.9 | 41,859 | Common Stock |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 23 Dec 2022 | 142,013 | 387,136 (1%) | 0% | 0.4 | 58,680 | Common Stock |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2022 | 142,013 | 0 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 388,000 | 388,000 | - | - | Stock Option (Right to Buy) | |
| Talaris Therapeutics Inc | Geoff Mackay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 14,501 | 14,501 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 405,000 | 405,000 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 328,500 | 328,500 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 343,850 | 343,850 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.41 per share. | 24 Dec 2020 | 100,000 | 245,123 (0%) | 0% | 0.4 | 41,320 | Common Stock |
| Tectonic Therapeutic Inc. | Geoff Mackay | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Dec 2020 | 100,000 | 142,013 | - | - | Stock Option (Right to Buy) |